NEW YORK (TheStreet) -- Shares of The Clorox Co. (CLX) are up 2.19% to $102.02 in early morning trading on Tuesday after the company's price target, EPS estimates, and cash flow per share estimates were increased at BMO Capital Markets.
The firm set a price target of $101--up from its previous mark of $85--for the multinational consumer, professional manufacturing and marketing company.
BMO Capital increased annual EPS estimates for the company to $4.50 from $438 for fiscal 2015, and to $4.70 from $4.61 for fiscal 2016.
Must Read: Warren Buffett's 25 Favorite Stocks
The firm also raised Clorox's annual CFPS (cash flow per share) estimates to $1.39 from $1.34 for fiscal 2015, and to $1.48 from $1.40 for fiscal 2016.
BMO Capital reiterated its "market perform" rating and said the company is cutting costs.
Separately, TheStreet Ratings team rates CLOROX CO/DE as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate CLOROX CO/DE (CLX) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, expanding profit margins, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income."